SHM Joins Multi-Stakeholder Letter Urging Passage of MAT Act
SHM joined nearly 200 organizations urging Congress to pass the Mainstreaming Addiction Treatment Act before the end of the 117th Congressional session.
Search
Displaying 1 - 10 of 16 results for
SHM Joins Multi-stakeholder Letter Urging Congress to Remove Restrictions on Buprenorphine
SHM joined a multi-stakeholder letter urging Congress to expand access to buprenorphine. The letter urged Congress to include legislation to address the opioid epidemic in the upcoming COVID
SHM Joins Multi-Stakeholder Letter Supporting the Elimination of the X-Waiver
SHM joined a multi-stakeholder letter urging the Acting Secretary of Health and Human Services (HHS) to finalize guidelines that would expand access to buprenorphine.
Letter
SHM Sends Letter to Energy and Commerce Republicans on Opioid Use Disorder Treatment
SHM responds to the House Energy and Commerce Republicans' request for information regarding opioid and substance use disorder treatment. This letter focuses specifically on the need to deregulate
Letter
SHM Supports the Mainstreaming Addiction Treatment Act
The Mainstreaming Addiction Treatment Act (S. 2074) is the companion bill to H.R. 2482. This bill will increase access to buprenorphine, a lifesaving addiction treatment, by eliminating the "X
Letter
SHM Submits a Letter of Support for Opioid Legislation
SHM sent a support letter to Reps. Blumenauer and Mullin for their legislation, the Overdose Prevention and Patient Safety Act.
Letter
SHM Publishes Policy Statement Addressing the Opioid Epidemic
SHM urges Congress to take action to address the opioid crisis facing the United States.
Letter
SHM Submits Comments to CMS on OPPS Proposed Rule
SHM submitted comments regarding the pain management questions in the HCAHPS survey to Medicare in the Outpatient Prospective Payment System (OPPS) proposed rule.
Letter
SHM Signs on to Letter Supporting Antibiotic Stewardship Requirements for LTCFs
Along with other organizations, SHM signs onto a letter to CMS supporting antibiotic stewardship requirements for long term care facilities (LTCFs) in order to participate in Medicare programs.
Letter
SHM Signs onto Letter to Congressional Leaders Regarding the Prescription Drug Monitoring Programs (PDMPs)
We write to you as leading participants in the prescription drug supply chain – i.e., manufacturers, distributors, payers, physicians, pharmacies, testing laboratories, treatment providers – as